GestaltMatcher facilitates rare disease matching using facial phenotype descriptors.


Journal

Nature genetics
ISSN: 1546-1718
Titre abrégé: Nat Genet
Pays: United States
ID NLM: 9216904

Informations de publication

Date de publication:
03 2022
Historique:
received: 31 12 2020
accepted: 16 12 2021
pubmed: 12 2 2022
medline: 28 4 2022
entrez: 11 2 2022
Statut: ppublish

Résumé

Many monogenic disorders cause a characteristic facial morphology. Artificial intelligence can support physicians in recognizing these patterns by associating facial phenotypes with the underlying syndrome through training on thousands of patient photographs. However, this 'supervised' approach means that diagnoses are only possible if the disorder was part of the training set. To improve recognition of ultra-rare disorders, we developed GestaltMatcher, an encoder for portraits that is based on a deep convolutional neural network. Photographs of 17,560 patients with 1,115 rare disorders were used to define a Clinical Face Phenotype Space, in which distances between cases define syndromic similarity. Here we show that patients can be matched to others with the same molecular diagnosis even when the disorder was not included in the training set. Together with mutation data, GestaltMatcher could not only accelerate the clinical diagnosis of patients with ultra-rare disorders and facial dysmorphism but also enable the delineation of new phenotypes.

Identifiants

pubmed: 35145301
doi: 10.1038/s41588-021-01010-x
pii: 10.1038/s41588-021-01010-x
pmc: PMC9272356
mid: NIHMS1815116
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

349-357

Subventions

Organisme : NIGMS NIH HHS
ID : R35 GM133408
Pays : United States

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.

Références

Ferreira, C. R. The burden of rare diseases. Am. J. Med. Genet. A 179, 885–892 (2019).
doi: 10.1002/ajmg.a.61124
Baird, P. A., Anderson, T. W., Newcombe, H. B. & Lowry, R. B. Genetic disorders in children and young adults: a population study. Am. J. Hum. Genet. 42, 677–693 (1988).
pubmed: 3358420 pmcid: 1715177
Hart, T. C. & Hart, P. S. Genetic studies of craniofacial anomalies: clinical implications and applications. Orthod. Craniofac. Res. 12, 212–220 (2009).
doi: 10.1111/j.1601-6343.2009.01455.x
Marbach, F. et al. The discovery of a LEMD2-associated nuclear envelopathy with early progeroid appearance suggests advanced applications for AI-driven facial phenotyping. Am. J. Hum. Genet. 104, 749–757 (2019).
doi: 10.1016/j.ajhg.2019.02.021
Ferry, Q. et al. Diagnostically relevant facial gestalt information from ordinary photos. eLife 3, e02020 (2014).
doi: 10.7554/eLife.02020
Kuru, K., Niranjan, M., Tunca, Y., Osvank, E. & Azim, T. Biomedical visual data analysis to build an intelligent diagnostic decision support system in medical genetics. Artif. Intell. Med. 62, 105–118 (2014).
doi: 10.1016/j.artmed.2014.08.003
Cerrolaza, J. J. et al. Identification of dysmorphic syndromes using landmark-specific local texture descriptors. In 2016 IEEE 13th International Symposium on Biomedical Imaging (ISBI) 1080–1083 (IEEE, 2016).
Wang, K. & Luo, J. Detecting visually observable disease symptoms from faces. EURASIP J. Bioinform. Syst. Biol. 2016, 13 (2016).
doi: 10.1186/s13637-016-0048-7
Dudding-Byth, T. et al. Computer face-matching technology using two-dimensional photographs accurately matches the facial gestalt of unrelated individuals with the same syndromic form of intellectual disability. BMC Biotechnol. 17, 90 (2017).
doi: 10.1186/s12896-017-0410-1
Shukla, P., Gupta, T., Saini, A., Singh, P. & Balasubramanian, R. A deep learning frame-work for recognizing developmental disorders. In 2017 IEEE Winter Conference on Applications of Computer Vision (WACV) 705–714 (IEEE, 2017).
Liehr, T. et al. Next generation phenotyping in Emanuel and Pallister–Killian syndrome using computer-aided facial dysmorphology analysis of 2D photos. Clin. Genet. 93, 378–381 (2018).
doi: 10.1111/cge.13087
Gurovich, Y. et al. Identifying facial phenotypes of genetic disorders using deep learning. Nat. Med. 25, 60–64 (2019).
doi: 10.1038/s41591-018-0279-0
van der Donk, R. et al. Next-generation phenotyping using computer vision algorithms in rare genomic neurodevelopmental disorders. Genet. Med. 21, 1719–1725 (2019).
doi: 10.1038/s41436-018-0404-y
Taigman, Y., Yang, M., Ranzato, M. & Wolf, L. DeepFace: closing the gap to human-level performance in face verification. In Proceedings of the IEEE Computer Society Conference on Computer Vision and Pattern Recognition 1701–1708 (IEEE Computer Society, 2014).
Huang, G. B., Ramesh, M., Berg, T. & Learned-Miller, E. Labeled Faces in the Wild: A Database for Studying Face Recognition in Unconstrained Environments. University of Massachusetts, Amherst, Technical Report 07–49 (2007).
Pantel, J. T. et al. Efficiency of computer-aided facial phenotyping (DeepGestalt) in individuals with and without a genetic syndrome: diagnostic accuracy study. J. Med. Internet Res. 22, e19263 (2020).
doi: 10.2196/19263
Landrum, M. J. et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 46, D1062–D1067 (2018).
doi: 10.1093/nar/gkx1153
McKusick, V. A. On lumpers and splitters, or the nosology of genetic disease. Perspect. Biol. Med. 12, 298–312 (1969).
doi: 10.1353/pbm.1969.0039
Yi, D., Lei, Z., Liao, S. & Li, S. Z. Learning face representation from scratch. Preprint at arXiv [cs.CV], http://arxiv.org/abs/1411.7923 (2014).
Winter, R. M. & Baraitser, M. The London Dysmorphology Database. J. Med. Genet. 24, 509–510 (1987).
doi: 10.1136/jmg.24.8.509
Sobreira, N., Schiettecatte, F., Valle, D. & Hamosh, A. GeneMatcher: a matching tool for connecting investigators with an interest in the same gene. Hum. Mutat. 36, 928–930 (2015).
doi: 10.1002/humu.22844
Stankiewicz, P. et al. Haploinsufficiency of the chromatin remodeler BPTF causes syndromic developmental and speech delay, postnatal microcephaly, and dysmorphic features. Am. J. Hum. Genet. 101, 503–515 (2017).
doi: 10.1016/j.ajhg.2017.08.014
Morimoto, M. et al. Bi-allelic CCDC47 variants cause a disorder characterized by woolly hair, liver dysfunction, dysmorphic features, and global developmental delay. Am. J. Hum. Genet. 103, 794–807 (2018).
doi: 10.1016/j.ajhg.2018.09.014
Tanaka, A. J. et al. De novo pathogenic variants in CHAMP1 are associated with global developmental delay, intellectual disability, and dysmorphic facial features. Cold Spring Harb. Mol. Case Stud. 2, a000661 (2016).
doi: 10.1101/mcs.a000661
Weiss, K. et al. De novo mutations in CHD4, an ATP-dependent chromatin remodeler gene, cause an intellectual disability syndrome with distinctive dysmorphisms. Am. J. Hum. Genet. 99, 934–941 (2016).
doi: 10.1016/j.ajhg.2016.08.001
Balak, C. et al. Rare de novo missense variants in RNA helicase DDX6 cause intellectual disability and dysmorphic features and lead to P-body defects and RNA dysregulation. Am. J. Hum. Genet. 105, 509–525 (2019).
doi: 10.1016/j.ajhg.2019.07.010
Harms, F. L. et al. Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia, and facial dysmorphism. Am. J. Hum. Genet. 100, 117–127 (2017).
doi: 10.1016/j.ajhg.2016.11.012
Jansen, S. et al. De novo variants in FBXO11 cause a syndromic form of intellectual disability with behavioral problems and dysmorphisms. Eur. J. Hum. Genet. 27, 738–746 (2019).
doi: 10.1038/s41431-018-0292-2
Au, P. Y. B. et al. GeneMatcher aids in the identification of a new malformation syndrome with intellectual disability, unique facial dysmorphisms, and skeletal and connective tissue abnormalities caused by de novo variants in HNRNPK. Hum. Mutat. 36, 1009–1014 (2015).
doi: 10.1002/humu.22837
Diets, I. J. et al. De novo and inherited pathogenic variants in KDM3B cause intellectual disability, short stature, and facial dysmorphism. Am. J. Hum. Genet. 104, 758–766 (2019).
doi: 10.1016/j.ajhg.2019.02.023
Santiago-Sim, T. et al. Biallelic variants in OTUD6B cause an intellectual disability syndrome associated with seizures and dysmorphic features. Am. J. Hum. Genet. 100, 676–688 (2017).
doi: 10.1016/j.ajhg.2017.03.001
Olson, H. E. et al. A recurrent de novo PACS2 heterozygous missense variant causes neonatal-onset developmental epileptic encephalopathy, facial dysmorphism, and cerebellar dysgenesis. Am. J. Hum. Genet. 102, 995–1007 (2018).
doi: 10.1016/j.ajhg.2018.03.005
Stephen, J. et al. Bi-allelic TMEM94 truncating variants are associated with neurodevelopmental delay, congenital heart defects, and distinct facial dysmorphism. Am. J. Hum. Genet. 103, 948–967 (2018).
doi: 10.1016/j.ajhg.2018.11.001
Kanca, O. et al. De novo variants in WDR37 are associated with epilepsy, colobomas, dysmorphism, developmental delay, intellectual disability, and cerebellar hypoplasia. Am. J. Hum. Genet. 105, 413–424 (2019).
doi: 10.1016/j.ajhg.2019.06.014
Stevens, S. J. C. et al. Truncating de novo mutations in the Krüppel-type zinc-finger gene ZNF148 in patients with corpus callosum defects, developmental delay, short stature, and dysmorphisms. Genome Med. 8, 131 (2016).
doi: 10.1186/s13073-016-0386-9
Alvi, M., Zisserman, A. & Nellåker, C. Turning a blind eye: explicit removal of biases and variation from deep neural network embeddings. In Computer Vision – ECCV 2018 Workshops 556–572 (Springer International Publishing, 2019).
Lumaka, A. et al. Facial dysmorphism is influenced by ethnic background of the patient and of the evaluator. Clin. Genet. 92, 166–171 (2017).
doi: 10.1111/cge.12948
Schuurs-Hoeijmakers, J. H. M. et al. Recurrent de novo mutations in PACS1 cause defective cranial-neural-crest migration and define a recognizable intellectual-disability syndrome. Am. J. Hum. Genet. 91, 1122–1127 (2012).
doi: 10.1016/j.ajhg.2012.10.013
van der Maaten, L. & Hinton, G. Visualizing data using t-SNE. J. Mach. Learn. Res. 9, 2579–2605 (2008).
Rousseeuw, P. J. Silhouettes: a graphical aid to the interpretation and validation of cluster analysis. J. Comput. Appl. Math. 20, 53–65 (1987).
doi: 10.1016/0377-0427(87)90125-7
Ebstein, F. et al. De novo variants in the PSMC3 proteasome AAA-ATPase subunit gene cause neurodevelopmental disorders associated with type I interferonopathies. Preprint at medRxiv https://doi.org/10.1101/2021.12.07.21266342 (2021).
Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405–424 (2015).
doi: 10.1038/gim.2015.30
Tavtigian, S. V. et al. Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework. Genet. Med. 20, 1054–1060 (2018).
doi: 10.1038/gim.2017.210
Philippakis, A. A. et al. The Matchmaker Exchange: a platform for rare disease gene discovery. Hum. Mutat. 36, 915–921 (2015).
doi: 10.1002/humu.22858
Nguengang Wakap, S. et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur. J. Hum. Genet. 28, 165–173 (2020).
doi: 10.1038/s41431-019-0508-0

Auteurs

Tzung-Chien Hsieh (TC)

Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.

Shahida Moosa (S)

Division of Molecular Biology and Human Genetics, Stellenbosch University and Medical Genetics, Tygerberg Hospital, Tygerberg, South Africa.

Nadja Ehmke (N)

Institute of Medical Genetics and Human Genetics, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.

Karen W Gripp (KW)

A.I. DuPont Hospital for Children/Nemours, Wilmington, DE, USA.

Jean Tori Pantel (JT)

Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.
Institute of Medical Genetics and Human Genetics, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.

Magdalena Danyel (M)

Institute of Medical Genetics and Human Genetics, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
Berlin Center for Rare Diseases, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.

Martin Atta Mensah (MA)

Institute of Medical Genetics and Human Genetics, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
BIH Biomedical Innovation Academy, Digital Clinician Scientist Program, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.

Denise Horn (D)

Institute of Medical Genetics and Human Genetics, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.

Stanislav Rosnev (S)

Institute of Medical Genetics and Human Genetics, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.

Nicole Fleischer (N)

FDNA Inc., Boston, MA, USA.

Guilherme Bonini (G)

FDNA Inc., Boston, MA, USA.

Alexander Hustinx (A)

Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.

Alexander Schmid (A)

Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.

Alexej Knaus (A)

Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.

Behnam Javanmardi (B)

Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.

Hannah Klinkhammer (H)

Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.
Institute for Medical Biometry, Informatics and Epidemiology, Medical Faculty, University of Bonn, Bonn, Germany.

Hellen Lesmann (H)

Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.

Sugirthan Sivalingam (S)

Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.
Institute for Medical Biometry, Informatics and Epidemiology, Medical Faculty, University of Bonn, Bonn, Germany.
Core Unit for Bioinformatics Data Analysis, Medical Faculty, University of Bonn, Bonn, Germany.

Tom Kamphans (T)

GeneTalk, Bonn, Germany.

Wolfgang Meiswinkel (W)

GeneTalk, Bonn, Germany.

Frédéric Ebstein (F)

Institut für Medizinische Biochemie und Molekularbiologie (IMBM), Universitätsmedizin Greifswald, Greifswald, Germany.

Elke Krüger (E)

Institut für Medizinische Biochemie und Molekularbiologie (IMBM), Universitätsmedizin Greifswald, Greifswald, Germany.

Sébastien Küry (S)

CHU Nantes, Service de Génétique Médicale, Nantes, France.
l'Institut du Thorax, INSERM, CNRS, Université de Nantes, Nantes, France.

Stéphane Bézieau (S)

CHU Nantes, Service de Génétique Médicale, Nantes, France.
l'Institut du Thorax, INSERM, CNRS, Université de Nantes, Nantes, France.

Axel Schmidt (A)

Institute of Human Genetics, University of Bonn, Medical Faculty & University Hospital Bonn, Bonn, Germany.

Sophia Peters (S)

Institute of Human Genetics, University of Bonn, Medical Faculty & University Hospital Bonn, Bonn, Germany.

Hartmut Engels (H)

Institute of Human Genetics, University of Bonn, Medical Faculty & University Hospital Bonn, Bonn, Germany.

Elisabeth Mangold (E)

Institute of Human Genetics, University of Bonn, Medical Faculty & University Hospital Bonn, Bonn, Germany.

Martina Kreiß (M)

Institute of Human Genetics, University of Bonn, Medical Faculty & University Hospital Bonn, Bonn, Germany.

Kirsten Cremer (K)

Institute of Human Genetics, University of Bonn, Medical Faculty & University Hospital Bonn, Bonn, Germany.

Claudia Perne (C)

Institute of Human Genetics, University of Bonn, Medical Faculty & University Hospital Bonn, Bonn, Germany.

Regina C Betz (RC)

Institute of Human Genetics, University of Bonn, Medical Faculty & University Hospital Bonn, Bonn, Germany.

Tim Bender (T)

Institute of Human Genetics, University of Bonn, Medical Faculty & University Hospital Bonn, Bonn, Germany.
Center for Rare Diseases Bonn, University Hospital Bonn, Bonn, Germany.

Kathrin Grundmann-Hauser (K)

Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.

Tobias B Haack (TB)

Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.

Matias Wagner (M)

Institute of Human Genetics, School of Medicine, Technical University Munich, Munich, Germany.
Institute of Neurogenomics, Helmholtz Zentrum München GmbH, German Research Center for Environmental Health, Neuherberg, Germany.

Theresa Brunet (T)

Institute of Human Genetics, School of Medicine, Technical University Munich, Munich, Germany.
Institute of Neurogenomics, Helmholtz Zentrum München GmbH, German Research Center for Environmental Health, Neuherberg, Germany.

Heidi Beate Bentzen (HB)

Norwegian Research Center for Computers and Law, Faculty of Law, University of Oslo, Oslo, Norway.

Luisa Averdunk (L)

Department of General Pediatrics, Neonatology and Pediatric Cardiology, Medical Faculty, University Hospital, Heinrich-Heine-University, Düsseldorf, Germany.

Kimberly Christine Coetzer (KC)

Division of Molecular Biology and Human Genetics, Stellenbosch University and Medical Genetics, Tygerberg Hospital, Tygerberg, South Africa.

Gholson J Lyon (GJ)

Department of Human Genetics and George A. Jervis Clinic, NYS Institute for Basic Research in Developmental Disabilities, Staten Island, NY, USA.
Biology PhD Program, The Graduate Center, The City University of New York, New York, NY, USA.

Malte Spielmann (M)

Institute of Human Genetics, University of Lübeck, Lübeck, Germany.

Christian P Schaaf (CP)

Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.

Stefan Mundlos (S)

Institute of Medical Genetics and Human Genetics, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.

Markus M Nöthen (MM)

Institute of Human Genetics, University of Bonn, Medical Faculty & University Hospital Bonn, Bonn, Germany.

Peter M Krawitz (PM)

Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany. pkrawitz@uni-bonn.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH